Abstract
Posterior reversible encephalopathy syndrome (PRES) is well-described in adults, but has been reported with relative rarity in children, usually occurring in the context of chemotherapy for acute leukemia. Pathogenesis involves perturbed cerebral autoregulation leading to vasogenic edema predominantly affecting the parieto-occipital white matter, though involvement of the frontal and temporal lobes, as well as posterior fossa, is also described. We review the literature on the pathophysiology, diagnosis, and management of PRES in pediatric patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2365-2372 |
| Number of pages | 8 |
| Journal | Leukemia and Lymphoma |
| Volume | 60 |
| Issue number | 10 |
| DOIs | |
| State | Published - Aug 24 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Hematology
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Posterior reversible encephalopathy syndrome in pediatric patients: pathophysiology, diagnosis, and management'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver